Abstract
Ethical and regulatory aspects are important in practice of medicine, and the same applies to nanomedicine. As has happened with introduction of all new technologies, in healthcare, these issues need to be considered. The FDA is formulating specific regulations relevant to nanobiotechnology products. The development of pharmaceuticals containing nanoparticles and methods of drug delivery, however, will be regulated by the FDA like any other biopharmaceutical product.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Allhoff F, et al (eds). Nanoethics: The Ethical and Social Implications of Nanotechnology. John Wiley & Sons, New York, 2007.
Bawa R. Patents and nanomedicine. Nanomed 2007;2:351–74.
Borm PJ, Robbins D, Haubold S, et al. The potential risks of nanomaterials: a review carried out for ECETOC. Part Fibre Toxicol 2006;3:11.
Dupuy JP. Some pitfalls in the philosophical foundations of nanoethics. J Med Philos 2007;32:237–61.
Fiedler FA, Reynolds GH. Legal Problems of Nanotechnology: An Overview. Southern California Interdisciplinary Law Journal, Winter 1994.
Gamer AO, Leibold E, van Ravenzwaay B. The in vitro absorption of microfine zinc oxide and titanium dioxide through porcine skin. Toxicol In Vitro 2006;20:301–7.
Gaspar R. Regulatory issues surrounding nanomedicines: setting the scene for the next generation of nanopharmaceuticals. Nanomedicine 2007;2:143–147.
Geert van Calster. Regulating Nanotechnology in the European Union. Nanotechnology Law & Business 2006;3:359–72.
Gordijn B. Nanoethics: from utopian dreams and apocalyptic nightmares towards a more balanced view. Sci Eng Ethics 2005;11:521–33.
Jain KK, Jain V. Impact of Nanotechnology on Healthcare. Nanotechnology Law & Business 2006;3:411–8.
Monica JC. FDA Labeling of Cosmetics Containing Nanoscale Materials, Nanotechnology Law & Business 2008;5:63–72.
Parr D. Will nanotechnology make the world a better place? Trends Biotechnol 2005;23:395–8.
Resnik DB, Tinkle SS. Ethics in nanomedicine. Nanomedicine 2007;2:345–50.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media New York
About this chapter
Cite this chapter
Jain, K.K. (2012). Ethical and Regulatory Aspects of Nanomedicine. In: The Handbook of Nanomedicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-983-9_18
Download citation
DOI: https://doi.org/10.1007/978-1-61779-983-9_18
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-982-2
Online ISBN: 978-1-61779-983-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)